Harvard Bioscience Investor Relations Material
Latest events
Q3 2024
Harvard Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Harvard Bioscience Inc
Access all reports
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. It operates in two segments, Lab Products Group and Specialty Life Science Group. The Specialty Life Science Group segment manufactures and sells specialized life science research products to pharmaceutical companies and academic institutions. This segment offers large protein electrophysiological instrumentation, including voltage or current-clamp amplifiers; multi-photon excitation instruments used in optical imaging; scientific cameras and software; advanced microscopy; cell charting systems that detect morphological changes in cells; mass spectrometers; respirometers and other physiological measurement equipment; syringe pumps; microinjectors for small animals; oxygenators for tissue engineering applications used for cell culture work on a laboratory benchtop.
Key slides for Harvard Bioscience Inc
Sidoti Micro-Cap Virtual Conference
Harvard Bioscience Inc
Q2 2024
Harvard Bioscience Inc
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
HBIO
Country
🇺🇸 United States